The 4th Adverse Events Reporting and Safety Strategies Summit, taking place December 4–5 in Philadelphia, will offer in-depth analysis of benefit-risk assessments, real-world data, risk management plans, signal detection, periodic reporting and solicited/unsolicited reports.
This participant-driven summit illustrates why it is the event of choice for AE and drug safety for insightful thought leaders, seasoned professionals and savvy leaders from the realm of PV.
If you haven’t registered for the 4th Adverse Events Reporting and Safety Strategies Summit, secure your seat today!
ExL Events’ 14th Clinical Performance Metrics Summit — December 4–5, 2017 in Philadelphia — brings together senior-level executives from pharmaceutical and biotechnology companies to examine case studies and solution-driven applications of clinical performance metrics. This meeting is designed to ensure that the audience leaves educated and equipped with best practices to help their organizations operate more efficiently while preserving their bottom line.
Join other metrics professionals at the industry’s longest-running clinical performance metrics summit by registering today!
Brochure Register Visit Website
Can you Switch? Should you Switch? With nearly half of proposed Switches failing, the industry must determine new initiatives in the early stages of a Switch process to identify viable and novel Switch candidates. In order to do this, your organization must overcome a number of challenges.
Attending the 4th RX-to-OTC Switch Summit on December 6–7, 2017 in Philadelphia, will provide you with an advanced understanding of how to produce successful switches and what future innovations are on the horizon. Explore detailed examinations of how advancements in technology are enabling switches, discover how organizations have achieved successful switches, learn to drive innovative medical and regulatory strategies and interact effectively with the FDA — and that’s not all.
If you haven’t registered for the 4th Rx-to-OTC Switch Forum, secure your seat today!
Join us for the 6th Content Marketing for Life Science Conference — December 6–7 in Philadelphia — to hear novel strategies to enhance customer experience through storytelling. With two days of informative sessions and networking opportunities, our experts will help you discover the nexus of content, channels, technology, analytics, and compliance.
Multiple functional teams and stakeholders provide their insight and analysis at various points of a product’s life cycle to help navigate the competitive landscape. New product planning professionals play a key role in streamlining these communications across functional lines and maintaining product-specific knowledge throughout the different stages of development.
Taking place December 7–8 in Boston, the 2nd New Product Planning Summit serves as a platform for product development, brand management, and marketing teams to learn how to improve early-stage decision making, optimize lifecycle management and tailor a product plan to ensure the successful commercialization of a new drug.
The 2nd Boston Medical Affairs Seminar, taking place December 7–8, 2017 at the Revere Hotel Boston Common, is an educational forum that addresses the strategic and operational challenges in medical affairs. It will feature presentations and interactive workshop panels, and provide attendees with the chance to advance their MA functions by learning about the following:
This is your opportunity to network with and learn from executive-level faculty speakers who are eager to share their knowledge and experiences! Join us now!
Kelly Willenberg LLC is a full service research compliance organization serving clients on improving operations. She employs technologies to improve operational aspects of compliance based on client needs. She assists in the implementation of billing compliance programs, offers training seminars, builds coverage analysis and helps with process improvement. She can also assist with process improvement, quality assurance and assessing vulnerabilities in all aspects of research compliance.
FiercePharma is a digital media publication, reporting and delivering daily news and objective analysis for business professionals in global industries. FiercePharma offers broad coverage serving a wide range of specific functional interests, including manufacturing regulation, financial management, quality control and production methods; shareholder pressure and speed-to-market strategies; sales and marketing access to physicians and navigating payer rules; the impact of pricing and partnerships on the pipeline; and the influence of big data, executive moves and social media on it all.
MAPS is the premier non-profit global society of Medical Affairs professionals across a spectrum of fields, experience, and locales. With our non-profit status, MAPS is able to reinvest all revenue back into the society, which ensures our ability to create valuable programs and resources that support the Medical Affairs community. MAPS is transforming the Medical Affairs industry to increase its value to companies and, ultimately, benefit patients and consumers.
7th CROWN Congress Mentioned in Interview With Janssen’s GxP Systems Strategy Director
ExL Events is so excited to thank Applied Clinical Trials for mentioning our 7th CROWN Congress once again in a new interview with Joe Pollarine, Head of GxP Systems Strategy Director at Janssen — who recently presented on CRO oversight models at the 8th Clinical Quality Oversight Forum. ExL’s 7th CROWN Congress takes place on January 23–25, 2018 in Philadelphia. In this new interview, Pollarine expanded on CRO oversight models and more.
In addition to conferences, ExL Events also provides industry-related content through a variety of social platforms. Be sure to follow the profiles that fit your topics of interest to gain access to the latest content and industry news.
Fill out our form to receive topic-specific conference emails as well as updates.